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Background: Several association studies with small sample sizes of two SNPs in IL28BB (rs12979860 and rs8099917)
showed inconsistent results, so in this study, we aim to evaluate the association between the two SNPs and infection
susceptibility of Hepatitis B Virus (HBV) in Asian population, especially in Chinese population by meta-analysis.
Methods: Search the relevant published papers and perform meta-analysis respectively on IL28B (rs12979860 and
rs8099917) in Asian population and Chinese population under an additive genetic model by STATA11.0.
Results: The pooled odds ratios (OR) of rs12979860 are 0.79 (95% CI, 0.53-1.18; P = 0.25, I2 = 63.2%) and 1.62 (95% CI,
1.04-2.51; P = 0.033, I2 = 54.3%) respectively in Asian population and Chinese population analysis. The pooled OR of
rs8099917 are 1.05 (95% CI, 0.93-1.19; P = 0.44, I2 = 43.3%) and 0.97 (95% CI, 0.84-1.23; P = 0.726, I2 = 15.6%) respectively
in Asian population and Chinese population analysis.
Conclusion: Our study demonstrated that T allele of rs12979680 can increase the risk of HBV infection in Chinese
population but not Asian population under an additive genetic model. There is no association between rs8099917 and
HBV infection in Chinese population and Asian population.
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Hepatitis B virus (HBV) is a worldwide health problem,
and it is estimated that 2 billion individuals have been
infected with HBV and 350 million are the chronic car-
riers. In the data of World Health Organization (WHO)
in 1997, the rate of chronic HBsAg carriers in Asian is
higher compared with other continents, HBsAg sero-
prevalence in the north and central Asian countries
ranged between 10% and 12% and in Southeast Asia it
ranged between 1% and 10% with a total number of 130
million. But in the United States and northern European
countries, it is under 0.5% [1]. In the Chinese epidemio-
logical investigation of HBV in 2006, the rate of chronic
HBsAg carriers was 7.18%, and it is about 93 million
patients with HBV chronic infection [2]. With the de-
velopment of human genome research, there is strong
evidence in HBV infection that host genetic factors play* Correspondence: bysyin@163.com
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The incidence of hepatitis B in Asian is high, so there
may be genetic susceptibility in Asian people. The re-
searchers have done much study on this issue in recent
years, and Interleukin 28B (IL28B) has been a hot re-
search topic on hepatitis virus, especially hepatic C
virus. IL28B plays an important role in the outcome of
hepatic C virus by genome-wide association studies
(GWAS) [3] and it could inhibit hepatitis B and C virus
replication [4]. HBV and HCV share some similarities
in pathogenesis, natural history and acquired immune
responses, but the relationship between ILB28 and HBV is
still unclear. Rs12979860 and rs8099917 were widely
studied in the previous research, so in this study, we
performed a meta-analysis on single nucleotide polymor-
phisms (SNPs) of IL28B (rs12979860 and rs8099917)
to evaluate the relationships between the genetic loci
and HBV in Asian population, especially in Chinese
population.icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Identification of eligible studies
We searched the databases including PubMed, MEDLINE,
EMBASE, China National Knowledge infrastructure (CNKI)
and WanFang database for case–control studies on IL28B
published in Asian population up to March, 2015. The
search terms included IL28B and Asian and HBV. Then
we selected the papers included IL28B-rs12979860 and
rs8099917 (Figure 1, Tables 1 and 2).Identification of eligible studies in PubMed, MED
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Figure 1 The flowchart of the meta-analysis.The criteria of articles included and excluded in the
meta-analysis
The articles included in the study should meet the follow-
ing criteria: (1) the subjects were the Asian population; (2)
the study was a case–control study including the HBV
group and the control group. All patients with HBV infec-
tion were selected for the study including chronic hepatitis
B patients, HBV-related HCC patients and inactive HBsAg
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Table 1 Characteristics of the papers included in the meta-analysis and allele frequency of IL28B rs12979860 (C-T)






C T C T
rs12979860 China Shi et al. [16] 2011 153 11 34 0
China Li et al. [10] 2011 760 104 382 24
China Chen et al. [17] 2012 2238 172 455 33
China Ren et al. [12] 2012 236 46 45 2
China Lv et al. [18] 2012 488 36 525 29
Korea Kim et al. [15] 2013 707 41 185 15
Thai KimKong et al. [19] 2015 398 24 304 24
Sum 4,980 434 1,930 127
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size and the number of genotype and the frequency of the
allele. (4) The papers should comply with the Hardy-
Weinberg equilibrium (HWE) in health control group (5)
Paper of the best quality was remained among the re-
peated published papers. (6) The papers should have been
performed with the ethical approval and patient consent.
The criteria of articles excluded from the study were:
(1) The papers of inappropriate statistically description
or methods were removed; (2) Studies in which IL28B
genotypes/alleles were not well defined (Figure 1).
Data extraction and analysis
We extracted data from the papers included (ethnicity,
genotypic distribution and allelic frequency) and performed
meta-analysis by STATA, version11.0 under an additive
genetic model. (Tables 2 and 3) The heterogeneity was
assessed by Cochran Q test (P <0.1 was considered to be
significant). The heterogeneity was classed by I2 statistical
test (I2 < 25%: low heterogeneity; I2 = 25–50%: moderate
heterogeneity; I2 = 50–75%: high heterogeneity; I2 > 75%:
extreme heterogeneity value) [5]. If P > 0.1 in Cochran Q
test, the pooled ORs and 95% CIs were calculated in
fixed effect model; otherwise in random effect model.Table 2 Characteristics of the papers included in the meta-an
SNP Area Author Year
rs8099917 China Li et al. [10] 2011
China Chen et al. [17] 2012
China Ren et al. [12] 2012
Korea Kim et al. [15] 2013
Thai Kimkong et al. [19] 2015
China Jiao et al. [11] 2011
China Ma et al. [20] 2012
SumPublication bias was evaluated by Begg’s test (P < 0.05 was
considered to be significant).Results
Results of meta-analysis of rs12979860 in Asian population
In the meta-analysis of rs12979860 in Asian population,
the pooled sample included 2,823 subjects with HBV in-
fection and 1,052 control subjects from 7 studies in Asian
population. There was high heterogeneity among studies
by Cochran Q test (P < 0.1, I2 = 63.2%) and a random effect
model was performed under an additive model. The
pooled OR of risk allele T was 0.79 (95% CI, 0.53-1.18; P =
0.25). No publication bias was found in the meta-analysis
(corrected ɀ = 0.30 and corrected p = 0.76) (Figure 2A,
Table 3).Results of meta-analysis of rs12979860 in Chinese
population
In the meta-analysis of rs12979860 in Chinese population,
the pooled sample included 2,238 subjects with HBV infec-
tion and 788 control subjects from 5 studies in Chinese
population. There was no heterogeneity among studies by







T G T G
764 48 385 21
2276 134 461 27
248 34 45 2
852 38 196 16
402 20 303 25
643 41 276 12
1494 90 947 67
6,679 405 2,989 170
Table 3 The result of meta-analysis of rs12979680 and rs8099917
SNPs Ethnicity Model Pooled OR (95%CI) P Heterogeneity Publication bias
I2 P ɀ P
rs12979680 Asian Random 0.79 (0.53-1.18) 0.25 63.2% <0. 1 0.30 0.76
rs12979680 Chinese Random 1.62 (1.04-2.51) 0.033 54.3% <0. 1 0.73 0.46
rs8099917 Asian Fixed 1.05 (0.93-1.19) 0.44 43.3% >0.1 0.9 0.37
rs8099917 Chinese Fixed 0.90 (0.84-1.81) 0.726 15.6% >0.1 1.71 0.09
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pooled OR of risk allele T was 1.62 (95% CI, 1.04-2.51; P =
0.033). No publication bias was found in the meta-analysis
(corrected ɀ = 0.73 and corrected p = 0.46) (Figure 2B,
Table 3).
Results of meta-analysis of rs8099917 in Asian population
In the meta-analysis of rs8099917, the pooled sample
included 3,613 subjects with HBV infection and 1,409
control subjects from 7 studies in Asian population.
There was no heterogeneity among studies by Cochran
Q test (P > 0.1, I2 = 43.3%) and a fixed effect model was
performed under an additive model. The pooled OR of
risk allele T was 1.05 (95% CI, 0.93-1.19; P = 0.44). No
publication bias was found in the meta-analysis (corrected
ɀ =0.9 and corrected p = 0.37) (Figure 3A, Table 3).
Results of meta-analysis of rs8099917 in Chinese population
In the meta-analysis of rs8099917, the pooled sample
included 3,048 subjects with HBV infection and 1,145
control subject from 5 studies in Chinese population.
There was no heterogeneity among studies by Cochran
Q test (P > 0.1, I2 = 15.6%) and a fixed effect model was
performed under an additive model. The pooled OR of
risk allele T was 0.97 (95% CI, 0.84-1.23; P = 0.726). No
publication bias was found in the meta-analysis (corrected
ɀ = 1.71 and corrected p = 0.09) (Figure 3B, Table 3).
Discussion
IL-28B belongs to the type III IFN family, and encodes a
cytokine related to type I interferons and the IL-10 fam-
ily. IL-28B, IL28A and IL29 are three closely related
cytokine genes located on 19q13. Expression of the three
genes can be induced by viral infection. Several GWAS
studies on the SNP loci affecting antiviral therapy of
HCV, and multiple SNPs on the IL28B gene were associ-
ated with sustained virological response (SVR). The link
was strongest among rsl2979860 3 kb upstream of IL28B
gene and rs8099917 8 kb upstream of the IL28B gene.
Rsl2979860 is significantly associated with the response
to Peg-IFN and ribavirin for patients with chronic HCV
infection. In a study to investigate the association between
rs12979860 and the end-of-treatment response (ETR) or
SVR in the Chinese Han population, genotype CC was the
main genotype (87.64%). The patients with genotype CChad higher rates of ETR and SVR than the patients with
CT or TT genotype [6]. There are differences in response
to treatment between patients of European ancestry and
African-Americans. In patients of European ancestry,
the CC genotype is associated with a twofold greater
rate of SVR than the TT genotype, threefold in African-
American and twofold in Hispanic population [7]. CC
genotype of rsl2979860 strongly enhances resolution of
HCV infection among individuals of both European
and African ancestry [8]. The studies above suggest that
the effect of rsl2979860 differs in races of diverse gen-
etic background.
In Chinese patients with dual chronic infection with
hepatitis B and C viruses, rs8099917 TG genotype could
increase the risk of null virological response (NVR)
(OR =2.37, P =0.017), and the GG genotype had a fur-
ther increased risk of NVR (OR = 4.23, P = 0.027). The
rs12979860 allele was associated with treatment failure
(CT/TT vs. CC: OR =2.04, P =0.037). IL28B rs8099917
G variant leads to higher risk of NVR (P = 0.009) in
HCV genotype 1 [8]. In GWAS to NVR in the treatment
of patients with HCV genotype 1 of Japanese population,
rs8099917 was strongly associated with NVR and SVR [9].
The relationship between IL28B and HCV is widely
studied, but the association study between IL28B and
HBV infection is much less and the results were incon-
sistent in previous studies. In two studies of rs12979680
on infection of hepatitis B virus in Chinese people, there
was no association between rs12979680 and HBV infec-
tion [10,11]. In another Chinese study, both C allele and
CC genotype were protective, which indicated that the
rs12979860 TC polymorphism is associated with the
carcinogenic process of chronic hepatitis B and HBV-
related HCC [12]. In a meta-analysis of rs12979680, no
significant correlation with HBV infection outcomes was
found, and the pooled OR was 0.42 (95% CI, 0.11-1.51; P =
0.184, I2 = 75.9%) in Asian population [13]. But in our
study, T allele of rs12979680 can increase the risk of HBV
infection in Chinese population but not Asian population
under an additive genetic model, the pooled OR (95% CIs)
were 1.62 (1.04–2.51). Compared with the previous meta-
analysis of rs12979680 (the included three papers was up-
dated in July 2013) [14], our study contains more papers
and more sample size. In the seven papers of our meta-
analysis, there are five studies on Chinese population, one
AB 
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Figure 2 Meta-analysis results of rs12979680(C-T) Panel A. Meta-analysis results of rs12979680(C-T) in Asian population. Panel B. Meta-analysis
results of rs12979680(C-T) in Chinese population.
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Figure 3 Meta-analysis results of rs8099917 (A -G) Panel A. Meta-analysis results of rs8099917 (A -G) in Asian population. Panel B. Meta-analysis
results of rs8099917 (A-G) in Chinese population.
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allele is 6.7 ~ 12.8% in Chinese population which is higher
compared with 5.5% in Korea population and 6.4% in Thai
population. The difference in the frequency of T allele in
China, Korea and Thai may explain the inconsistent result
in the meta-analysis on the Chinese population and the
Asian population. However, the papers included in the
meta-analysis are not enough and the result deserves more
research to testify.
In our meta-analysis of rs8099917, there is no association
between rs8099917 and susceptibility of HBV in both
Chinese population and the Asian population. Jiao et al.
demonstrate that rs8099917 is not associated with the
HBV infection [11], which is consistent with our result.
In another research, rs8099917 is strongly associated
with glutamic-pyruvic transaminase (ALT) level and HBV
viral load [10] IL28B rs8099917 AA genotype (AA vs
AC + CC: odds ratio (OR) = 0.63) was associated with a
decreased risk of HCC [13]. In a Korea study, rs8099917
is significantly associated with the outcomes of HBV infec-
tion [15]. The result deserves more research to testify.
Study limitations
There are several limitations that should be stated. First,
the frequency of the allele is not classified by the hepatitis
B virus genotypes which are different in different coun-
tries. Second, only seven papers were included in the
meta-analysis, and so the association between IL28B
(rs12979680 and rs8099917) and infection susceptibility
of HBV in this meta-analysis deserves further replication.
Conclusions
In summary, our study demonstrated that T allele of
rs12979680 can increase the risk of HBV infection in
Chinese population but not Asian population under an
additive genetic model. There is no association between
rs8099917 HBV infection in Chinese population and
Asian population.
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